NY Times - In the largest settlement involving a pharmaceutical company, the British drugmaker GlaxoSmithKline agreed to plead guilty to criminal charges and pay $3 billion in fines for promoting its best-selling antidepressants for unapproved uses and failing to report safety data about a top diabetes drug, federal prosecutors announced Monday…
UNDERNEWS
7.03.2012
But they're not, you know, really people so they won't serve time
Subscribe to:
Post Comments (Atom)
No comments:
Post a Comment